Upcoming gastrointestinal trials
TD 17.03 (LARK) - This study aims to show that incorporating Kilovoltage Intrafraction monitoring (KIM) in to liver SABR improves: treatment accuracy, patient treatment outcomes, and treatment efficiency.
Primary sponsor: TROG
TD 16.05 (ACT5) - this study aims to investigate the role of radiotherapy dose escalation in locally advanced anal cancer and determine if this can reduce local recurrence.
Primary sponsor: National Cancer Research Institute (NCRI)
Collaborating group: TROG